Pfizer Names Schulman Senior VP, General Counsel

Amy W. Schulman joins Pfizer from DLA Piper to lead the pharmaceutical company's legal division.

NEW YORK -- Pfizer Inc. today named Amy W. Schulman as Senior Vice President and General Counsel, effective June 23.

In her new role, Ms. Schulman will be responsible for leading Pfizer's legal division. She will serve on the company's Executive Leadership Team (ELT) and will report directly to Chairman and Chief Executive Officer Jeffrey B. Kindler.

Schulman joins Pfizer from DLA Piper where she handled legal, scientific and regulatory issues facing companies, including Pfizer. While at DLA Piper, Ms. Schulman served as lead national counsel in the multi-district litigation involving Bextra and Celebrex.

''Amy is a highly regarded and effective legal strategist who has vast experience leading large teams of attorneys,'' Mr. Kindler said. ''We are fortunate to have someone of her caliber join Pfizer. We know first hand the outstanding qualities that Amy brings to us. Her knowledge of the legal, business and regulatory challenges facing the pharmaceutical industry and her experience tackling large, complex cases make her uniquely qualified to lead Pfizer's legal team.''